These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8342326)
1. Immunoadjuvant activity of a liposomal IL-6 formulation. Duits AJ; van Puijenbroek A; Vermeulen H; Hofhuis FM; van de Winkel JG; Capel PJ Vaccine; 1993; 11(7):777-81. PubMed ID: 8342326 [TBL] [Abstract][Full Text] [Related]
2. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Chaitra MG; Nayak R; Shaila MS Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160 [TBL] [Abstract][Full Text] [Related]
3. Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Friede M; Muller S; Briand JP; Van Regenmortel MH; Schuber F Mol Immunol; 1993 Apr; 30(6):539-47. PubMed ID: 8487776 [TBL] [Abstract][Full Text] [Related]
4. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route. Ravindran R; Maji M; Ali N Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194 [TBL] [Abstract][Full Text] [Related]
5. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles. Gursel M; Gregoriadis G J Drug Target; 1998; 5(2):93-8. PubMed ID: 9588865 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits. Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice. Vangala A; Kirby D; Rosenkrands I; Agger EM; Andersen P; Perrie Y J Pharm Pharmacol; 2006 Jun; 58(6):787-99. PubMed ID: 16734980 [TBL] [Abstract][Full Text] [Related]
8. Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response. Davis D; Davies A; Gregoriadis G Immunol Lett; 1987 Apr; 14(4):341-8. PubMed ID: 3583325 [TBL] [Abstract][Full Text] [Related]
9. Influence of trehalose 6,6'-diester (TDX) chain length on the physicochemical and immunopotentiating properties of DDA/TDX liposomes. Kallerup RS; Madsen CM; Schiøth ML; Franzyk H; Rose F; Christensen D; Korsholm KS; Foged C Eur J Pharm Biopharm; 2015 Feb; 90():80-9. PubMed ID: 25445301 [TBL] [Abstract][Full Text] [Related]
10. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857 [TBL] [Abstract][Full Text] [Related]
11. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine. Hovav AH; Fishman Y; Bercovier H Infect Immun; 2005 Jan; 73(1):250-7. PubMed ID: 15618161 [TBL] [Abstract][Full Text] [Related]
12. Liposomal adjuvanticity: effect of encapsulation and surface-linkage on antibody production and proliferative response. Shahum E; Thérien HM Int J Immunopharmacol; 1995 Jan; 17(1):9-20. PubMed ID: 7782155 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant. Cargnelutti DE; Sanchez MA; Alvarez P; Boado L; Mattion N; Scodeller EA New Microbiol; 2013 Apr; 36(2):145-51. PubMed ID: 23686120 [TBL] [Abstract][Full Text] [Related]
14. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein. Hovav AH; Bercovier H Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV. Mansury D; Ghazvini K; Amel Jamehdar S; Badiee A; Tafaghodi M; Nikpoor AR; Amini Y; Jaafari MR Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):370-377. PubMed ID: 30691310 [TBL] [Abstract][Full Text] [Related]
16. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. de Haan A; Geerligs HJ; Huchshorn JP; van Scharrenburg GJ; Palache AM; Wilschut J Vaccine; 1995 Feb; 13(2):155-62. PubMed ID: 7625109 [TBL] [Abstract][Full Text] [Related]
17. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301 [TBL] [Abstract][Full Text] [Related]
18. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014 [TBL] [Abstract][Full Text] [Related]
19. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine. Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054 [TBL] [Abstract][Full Text] [Related]
20. Immunoadjuvant action of liposomes: comparison with other adjuvants. Gregoriadis G; Panagiotidi C Immunol Lett; 1989 Feb; 20(3):237-40. PubMed ID: 2714847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]